Dipna Pharmachem Ltd — Others, 08-08-2025: Others

Dipna Pharmachem's Annual Report for FY25 shows revenue dropped to ₹124.92 Cr from ₹164.34 Cr in the prior year, with profit after tax slightly declining to ₹0.97 Cr from ₹1.09 Cr. The company has announced an Annual General Meeting to approve these financial results, re-appoint a director, and appoint a new independent director. Shareholders will also vote on significant related party transactions, each up to ₹100 Cr, with three key entities. A proposal to increase authorized share capital from ₹25 Cr to ₹25.50 Cr is also on the agenda, signaling potential for future growth initiatives.